CNT co-director Chet Moritz speaks with Good Morning America about US FDA market authorization of ONWARD’s ARC-EX transcutaneous spinal cord stimulation system.
CNT co-director Chet Moritz speaks with Good Morning America about US FDA market authorization of ONWARD’s ARC-EX transcutaneous spinal cord stimulation system.